Fineotex Chemical Limited — Q1 FY26 earnings call

Call held 13 Aug 2025

Management summary

Fineotex Chemical Limited reported a strong Q1 FY26 with total income growing 15% QoQ to INR 146.22 crores and PAT increasing 25% QoQ to INR 25.03 crores. The company commissioned a new 15,000 MTPA plant, increasing total capacity to 120,000 MTPA, and is seeing a turnaround in its FMCG business. While gross margins were affected by product mix, management expects EBITDA margins to stabilize and improve, and is actively pursuing inorganic growth opportunities with a healthy cash balance.

Highlights

  • Total income increased by 15% QoQ to INR 146.22 crores.

  • PAT grew by 25% QoQ to INR 25.03 crores.

  • New greenfield plant commissioned, adding 15,000 MTPA capacity, bringing total to 120,000 MTPA.

  • FMCG business showing signs of turnaround, expected to return to peak volume by year-end.

  • Strong cash balance of over INR 360 crores available for inorganic growth opportunities.

Concerns

  • Gross profit margin at 34%, showing a 6% QoQ growth but a decline from previous levels, attributed to product mix shift.

  • Capacity utilization for the new plant was 59% in Q1, with potential for initial margin impact.

Key financials

  1. Total Income ₹146.22 Cr +15%QoQ
  2. Gross Profit ₹45.96 Cr +6%QoQ
  3. Gross Profit Margin 34%
  4. EBITDA ₹25.2 Cr +18.3%QoQ
  5. EBITDA Margin 18.3%
  6. PAT ₹25.03 Cr +25%QoQ
  7. PAT Margin 18.3%
  8. Sales Volume Growth — +14.7%QoQ
  9. ROCI 30.7%
  10. Exports Share 24%
  11. Capacity Utilization 59%

What they filed

Q1 FY27: revenue up 175.2%, net profit up 92.0% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue146 126 120 137 138 −5%184 +46%314 +162%377 +175%
EBITDA36 34 21 25 31 −14%35 +3%44 +110%59 +136%
Net profit32 28 20 25 26 −19%30 +7%44 +120%48 +92%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Segment breakdown

  • Revenue Mix (Volume Basis)
    70% Textile25% Health & Hygiene/FMCG5% Drilling/Oil & Gas
  • Revenue Mix (Value Basis)
    80% Textile20% Others

Capital allocation

high confidence
  • Capex Capex disclosed internal accruals and fund raise
    • New greenfield plant commissioning, adding 15,000 MTPA capacity
    This greenfield facility adds 15,000 metrics ton per annum of capacity, taking our total installed capacity to approx 120,000 metric tons per annum. Designed with a state-of-the-art manufacturing technology and a strong focus on environmental sustainability, this plant will enhance our ability to beat the rising global demand while adhering to highest ESG standards. This said, the expansion has been successfully executed within the planned timeline and budget funded through internal accruals and fund raise.
  • Debt Debt disclosed
    And all of them is done, it's a debt-free company. There is no loans on it for the expansion as well.
  • M&A Biotech Malaysia (historical) Acquisition · Integrated

    European technology with Asian cost

    Company has scaled very well since 2011 acquisition.

    The company has already done an inorganic acquisition in 2011. So after listing on 11th March 2011, within 3 months of the listing, we have used the IPO proceeds to acquire a stake in a European specialty chemical company producing the same range of chemicals, which has synergy with Fineotex, and it's been produced in Malaysia. The concept was to have the Asian cost and the European technology.
  • M&A Undisclosed Acquisition · Pending regulatory

    Synergy in businesses, EBITDA accretive from day 1, good value

    Potential for significant contribution to total revenues and profitability.

    In the last 2, 3 years, we have used to very advanced level of discussions with certain companies. Plus in the last quarter also, we have reached to advanced level of discussions. It's still under NDA. A lot of due diligence has been happened in the past. There are a lot of negotiations going on, things like that. In fact, I, this is, in fact, the right time to look at companies because due to this global, let's say, not so great scenario, most of the companies might not be doing so well. And maybe that has also reduced the target expectations. We are, I mean, this is just a general discussion. I'm not, so I think this is the right time for companies like us to go for the acquisition because this is a good time to buy.
  • Liquidity Cash ₹360 Cr Healthy cash balance available for inorganic opportunities after recent capex.
    The company has a healthy cash, cash on bank balance, which is more than INR360 crores right now after the capex of INR117 crores in the last 16 months, the company has already done that much of investments. So after that, this is the cash on bank, which the company is available for any such of inorganic opportunities.

Guidance & targets

Volume

  • FMCG Volume Volume · FY26 · High confidence Back to peak volume
    I am quite positive about that personally. By the end of the financial year, surely, we should be back on that track.

    — Sanjay Tibrewala

Margin

  • EBITDA Margin Margin · next couple of years · High confidence 18-20%
    for the next couple of years, we can keep it at around 18% to 20%.

    — Sanjay Tibrewala

  • EBITDA Margin Margin · after next couple of years · Medium confidence 24-25%
    And then after that, we can continue with the 24%, 25% that we have been doing.

    — Sanjay Tibrewala

Revenue

  • AquaStrike Revenue Revenue · next 1-2 months · Medium confidence Beginning to see commercial progress and revenues
    Now we are tying up on certain grounds. There is some factory verification process and approvals also, which is ongoing. We feel that in a month or 2 months' time maximum, we should be in a position to start beginning to see certain kind of progress on that numerical progress, commercial progress.

    — Sanjay Tibrewala

What to watch in Q2 FY26

AquaStrike commercial progress and revenue generation

next 1-2 months
Current Regulatory approvals cleared, factory verification ongoing
Target Beginning to see commercial progress and revenues

Why it matters

Key new product for diversification into mosquito repellent market.

in a month or 2 months' time maximum, we should be in a position to start beginning to see certain kind of progress on that numerical progress, commercial progress.

Risks & concerns

  • Gross margin compression due to product mix shift

    medium

    Gross margins were affected by a shift in product mix towards lower-margin polyester chemicals from cotton, not due to price reductions.

    Analyst acknowledged

  • Delay in AquaStrike commercialization

    medium

    Regulatory approvals are cleared, but factory verification and other approvals are ongoing, with commercial progress expected in 1-2 months.

    Analyst acknowledged

  • Past pain points in FMCG business

    medium

    The FMCG business had challenges in the past, but a turnaround is underway, with volumes expected to return to peak levels by year-end.

    Analyst acknowledged

  • Initial lower capacity utilization of new plant

    low

    The new plant operated at 59% utilization in Q1, which is considered normal for a new facility, with capacities being fungible and costs already incurred.

    Analyst acknowledged

  • Potential impact of US tariffs on textile orders

    low

    Direct exposure to the US market is negligible, and India is well-positioned to benefit from market shifts, using it as an opportunity for sustainable solutions.

    Analyst downplayed

Q&A highlights

7 direct
AquaStrike commercialization timeline Partial
Right now, as we are in August, there is a lot of, we have just completed quarter 1. We are very hopeful in the near future, we should have some right news on that.

Clarifies the expected timeline for revenue generation from a new product, which was previously mentioned as potentially delayed.

Asked by Aryan Kumar

New plant capacity utilization and Q2 margin impact Direct
So it's almost 59%... See, actually, before the plant gets commissioned 6 months before itself, there will be a lot of other kind of cost, revenue expenses, etc. And for the sake of getting the credit of the GST, we would always like to go for the revenue not for the capex kind of things.

Provides current capacity utilization for the new plant and explains that associated costs were already incurred, mitigating immediate Q2 margin impact.

Asked by Vinay Nadkarni

Gross margin decline explanation Direct
So that answer was regarding the gross margins that there are always such fluctuation of the kind of businesses, like say, let's say, polyester started growing more. And whenever polyester grows more, the consumption of the chemicals is slightly lower as well as it is not as profitable as in cotton. This is just one of the examples just to explain you, there is always a fluctuation in the trend.

Explains the reason for gross margin fluctuations, attributing it to product mix shifts rather than price reductions, which is crucial for understanding profitability.

Asked by Parth Patel

FMCG business turnaround Direct
I am quite positive about that personally. By the end of the financial year, surely, we should be back on that track.

Provides a clear timeline and positive outlook for the recovery of the FMCG segment, which had been a pain point.

Asked by Anupam Agarwal

Inorganic growth strategy and cash position Direct
To add to that, as you already know, perhaps that the company has a healthy cash, cash on bank balance, which is more than INR360 crores right now after the capex of INR117 crores in the last 16 months, the company has already done that much of investments. So after that, this is the cash on bank, which the company is available for any such of inorganic opportunities.

Highlights the company's strong financial position to pursue M&A and outlines the strategic criteria for potential acquisitions.

Asked by Parth Patel

Impact of US tariffs on textile orders Direct
So basically, they have to turn to Bangladesh, India, Pakistan, or countries like them. So this is the place where we are. As such, our direct exposure to U.S. is negligible.

Addresses a significant sector-wide concern, clarifying the company's limited direct exposure and potential opportunities arising from market shifts.

Asked by Devendra Kumar

Detergent market share growth and sustainable solutions Direct
So this is a continuous ongoing process, and we are proud to tell you that we have been focusing more on sustainable solutions... The faster the sustainability drive takes place in FMCG cleaning detergents, I think that will be a great move for us.

Explains the strategy behind increasing market share in detergents, focusing on sustainable solutions and aligning with industry trends.

Asked by Devendra Kumar

Revenue mix breakdown Direct
Right now, okay, I mean from the volume point of view, 70%, I think this question will arise again in a few minutes. So rather I share with all participants now. So, in a nutshell, the volume basis, textile is almost 70% in the quarter 1. Health and hygiene, FMCG is almost 25% and the remaining drilling is almost 5%.

Provides a clear breakdown of the company's product mix by volume, which is essential for understanding revenue drivers.

Asked by Vinay Nadkarni

3 min read 7 chapters

Detailed narrative

Q1 FY26 Financial Performance and Volume Growth

Fineotex Chemical Limited reported a robust Q1 FY26, with total income reaching INR 146.22 crores, marking a 15% increase quarter-on-quarter. Gross profit stood at INR 45.96 crores (34% margin), growing 6% QoQ, while EBITDA increased by 18.34% QoQ to INR 25.20 crores, with margins at 18.3%. The company's PAT saw a significant 25% QoQ rise to INR 25.03 crores, achieving an 18.26% margin. This performance was underpinned by a 14.73% increase in consolidated sales volume QoQ, reflecting healthy demand across key geographies and product categories.

Capacity Expansion and Utilization

The company successfully commissioned its new greenfield plant in Ambernath, spanning 3 lakh square feet, adding 15,000 metric tons per annum (MTPA) to its capacity. This expansion brings Fineotex's total installed capacity to approximately 120,000 MTPA. The new facility, designed with state-of-the-art technology and environmental sustainability, was funded through internal accruals and fund raises, with no additional debt. In Q1 FY26, the overall capacity utilization was approximately 59%, which management expects to scale up gradually.

Strategic Diversification into Oil & Gas and Water Treatment

Fineotex is strongly progressing in its diversification into water treatment and oil and gas verticals, leveraging its expertise to tap into significant growth potential. The company is seeing a growing pipeline of orders in both domestic and export markets, engaging with leading oil and gas companies. Management expressed confidence that these new divisions will contribute significantly to the company's total revenues and profitability, driven by higher upstream activity, refinery expansions, and stricter environmental regulations.

FMCG and Detergent Market Strategy

The company is actively focusing on sustainable solutions within the detergent market, which is a $50 billion global market. Management noted a continuous process of gaining market share by offering eco-friendly products, aligning with industry shifts towards acid-free and soda ash-free formulations. Despite past challenges, the FMCG business is showing a turnaround, with management expressing confidence that volumes will return to peak levels by the end of the financial year.

Gross Margin and EBITDA Margin Dynamics

Gross profit margins in Q1 FY26 were 34%, with management attributing fluctuations to shifts in product mix, specifically between polyester and cotton chemicals, rather than price reductions. While EBITDA margins were 18.3% in Q1, management guided for stabilization at 18-20% for the next couple of years, eventually returning to 24-25%. This improvement is expected as external factors become more supportive and the company optimizes its operational efficiencies.

Inorganic Growth Outlook and Financial Strength

Fineotex is actively exploring inorganic growth opportunities, with advanced discussions and due diligence ongoing for potential targets. The company maintains a disciplined approach, seeking acquisitions with strong business synergies and immediate EBITDA accretion. With a healthy cash balance of over INR 360 crores, even after a capex of INR 117 crores in the last 16 months, management believes it is an opportune time for acquisitions.

Textile Market and US Tariff Impact

Addressing concerns about US tariffs on textile imports, management clarified that Fineotex has negligible direct exposure to the US market. They emphasized India's strong position in the global textile supply chain, particularly with the opening of the UK market. The company views the current market dynamics as an opportunity to offer more sustainable and price-sensitive solutions, aiming to replace European co-producers in textile corporates.

This is an AI-generated summary of a publicly available earnings call transcript.
View original transcript

More Chemicals earnings calls